LGLotisha Garvin

Lotisha Garvin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lotisha Garvin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel D. Rockey

    Department of Biomedical Sciences, Oregon State University, Corvallis, Oregon, USA

    1 shared publication
  • Kevin Hybiske

    Affiliation Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, United States of America

    1 shared publication
  • Mary Dickinson

    Affiliation Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, United States of America

    1 shared publication
  • Rebecca Vande Voorde

    Affiliation Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America

    1 shared publication
  • Steven Carrell

    Affiliation Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America

    1 shared publication

Latest Publications

  • Open Access

    A broad-spectrum cloning vector that exists as both an integrated element and a free plasmid in Chlamydia trachomatis

    by Lotisha Garvin, Rebecca Vande Voorde, Mary Dickinson, Steven Carrell, Kevin Hybiske, Daniel Rockey

    Plasmid transformation of chlamydiae has created new opportunities to investigate host–microbe interactions during chlamydial infections; however, there are still limitations. Plasmid transformation requires a replicon derived from the native Chlamydia plasmid, and these transformations are species-specific. We explored the utility of a broad host-range plasmid, pBBR1MCS-4, to transform chlamydiae, with a goal of simplifying the transformation process. The plasmid was modified to contain chromosomal DNA from C. trachomatis to facilitate homologous recombination. Sequences flanking incA were cloned into the pBBR1MCS-4 vector along with the GFP:CAT cassette from the pSW2-GFP chlamydial shuttle vector. The final plasmid construct, pBVR2, was successfully transformed into C. trachomatis strain L2-434. Chlamydial transformants were analyzed by immunofluorescence microscopy and positive clones were sequentially purified using limiting dilution. PCR and PacBio-based whole genome sequencing were used to determine if the plasmid was maintained within the chromosome or as an episome. PacBio sequencing of the cloned transformants revealed allelic exchange events between the chromosome and plasmid pBVR2 that replaced chromosomal incA with the plasmid GFP:CAT cassette. The data also showed evidence of full integration of the plasmid into the bacterial chromosome. While some plasmids were fully integrated, some were maintained as episomes and could be purified and retransformed into E. coli. Thus, the plasmid can be successfully transformed into chlamydia without a chlamydial origin of replication and can exist in multiple states within a transformed population.